Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1908227
PUBLISHER: Grand View Research | PRODUCT CODE: 1908227
AI In Oncology Market Size, Share & Trends Analysis Report By Component Type, By Cancer Type, By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033
PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
AI In Oncology Market Summary
The global AI in oncology market size was estimated at USD 6.00 billion in 2025 and is expected to reach USD 38.91 billion by 2033, growing at a CAGR of 24.77% from 2026 to 2033. The growth of the market is attributed to increasing prevalence of cancer, technological advancement in cancer diagnostics & healthcare infrastructure, and an increasing demand for early detection and classification of cancer.
In addition, rising adoption of precision medicine is drives market growth further. The increasing incidence of cancer globally has led to a growing dependence on AI in the field of oncology. According to the NIH estimates of 2023, approximately 2.0 million individuals in the U.S. are diagnosed with cancer. Breast cancer was the most diagnosed cancer, with an estimated 297,790 cases in women and 2,800 cases in men. Among men, prostate cancer was the most frequently diagnosed cancer, and overall, it was the second most common diagnosis, with an anticipated 288,300 cases. The estimated number of new cases of lung and bronchus cancer made it the third most diagnosed cancer.
The growing initiatives undertaken by public and private organizations to invest in research and development (R&D) for introduction of novel technologies are further anticipated to fuel growth of the market. For instance, in October 2022, Tempus, a company specializing in precision medicine and AI, recently announced a program called Tempus+. This proprietary program utilizes real-world data to power collaborative precision oncology research. A community of researchers, including Baylor College of Medicine, Allegheny Health Network, Stanford Cancer Center, Rush University Medical Center, TriHealth, and others, is already using the Tempus+ program to advance their research. Furthermore, increasing product approval of AI-associated medical devices is anticipated to boost market growth. In January 2024, the U.S. FDA approved the first AI medical device, DermaSensor, to detect skin cancer.
The future of AI applications in cancer care is poised for groundbreaking advancements, encompassing early detection, precision medicine, and personalized treatment plans. AI's ability to analyze vast datasets, identify subtle patterns, and provide real-time insights holds the potential to revolutionize cancer diagnosis and therapy, ushering in a new era of improved patient outcomes and more efficient healthcare delivery.
Global AI In Oncology Market Report Segmentation
This report forecasts revenue growth and provides at global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global AI in oncology market report based on component type, cancer type, application, end use, and region:
- Component Type Outlook (Revenue, USD Million, 2021 - 2033)
- Software Solutions
- Hardware
- Services
- Cancer Type Outlook (Revenue, USD Million, 2021 - 2033)
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Colorectal Cancer
- Brain Tumor
- Others
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Diagnostics (Pathology, Cancer Radiology)
- Radiation therapy (Radiotherapy)
- Research & Development (Drug design, development process, etc.)
- Chemotherapy
- Immunotherapy
- End Use Type Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals
- Surgical Centers & Medical Institutes
- Others (Pharmaceutical companies, Research institutes & training centers)
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Product Code: GVR-4-68039-985-7
Table of Contents
Chapter 1. Methodology and Scope
- 1.1 Market Segmentation and Scope
- 1.1.1 Segment scope
- 1.1.2 Regional scope
- 1.1.3 Estimates and forecast timeline
- 1.2 Research Methodology
- 1.3 Information Procurement
- 1.3.1 Purchased database:
- 1.3.2 GVR's internal database
- 1.3.3 Secondary sources
- 1.3.4 Primary research
- 1.3.5 Details of primary research
- 1.4 Information or Data Analysis
- 1.4.1 Data analysis models
- 1.5 Market Formulation & Validation
- 1.6 Model Details
- 1.6.1 Commodity Flow Analysis
- 1.6.1.1 Approach: Commodity Flow Approach
- 1.6.1 Commodity Flow Analysis
- 1.7 Research Assumptions
- 1.8 List of Secondary Sources
- 1.9 List of Abbreviations
Chapter 2. Executive Summary
- 2.1 Market Outlook
- 2.2 Segment Outlook
- 2.3 Competitive Insights
Chapter 3. AI In Oncology Market Variables, Trends, & Scope
- 3.1 Market Lineage Outlook
- 3.1.1 Parent market sanalysis
- 3.2 Market Dynamics
- 3.2.1 Market drivers analysis
- 3.2.2 Market restraint analysis
- 3.2.3 Market opportunity analysis
- 3.2.4 Market challenges analysis
- 3.3 AI In Oncology: Market Analysis Tools
- 3.3.1 Industry analysis - Porter's Five Forces Analysis
- 3.3.2 PESTLE analysis
- 3.4 Case studies
Chapter 4. AI In Oncology Market Segment Analysis, By Component Type, 2021 - 2033 (USD Million)
- 4.1 Definition and Scope
- 4.2 Component Type Market Share Analysis, 2025 & 2033
- 4.3 Segment Dashboard
- 4.4 Global AI In Oncology Market, by Component, 2021 to 2033
- 4.5 Software Solutions
- 4.5.1 Software solutions market estimates and forecast, 2021 - 2033 (USD Million)
- 4.6 Hardware
- 4.6.1 Hardware market estimates and forecast, 2021 - 2033 (USD Million)
- 4.7 Services
- 4.7.1 Services market estimates and forecast, 2021 - 2033 (USD Million)
Chapter 5. AI In Oncology Market Segment Analysis, By Cancer Type, 2021 - 2033 (USD Million)
- 5.1 Definition and Scope
- 5.2 Cancer Type Market Share Analysis, 2025 & 2033
- 5.3 Segment Dashboard
- 5.4 Global AI In Oncology Market, by Cancer Type, 2021 to 2033
- 5.5 Breast Cancer
- 5.5.1 Breast cancer market estimates and forecast, 2021 - 2033 (USD Million)
- 5.6 Lung Cancer
- 5.6.1 Lung cancer market estimates and forecast, 2021 - 2033 (USD Million)
- 5.7 Prostate Cancer
- 5.7.1 Prostate cancer market estimates and forecast, 2021 - 2033 (USD Million)
- 5.8 Colorectal Cancer
- 5.8.1 Colorectal cancer market estimates and forecast, 2021 - 2033 (USD Million)
- 5.9 Brain Tumor
- 5.9.1 Brain tumor market estimates and forecast, 2021 - 2033 (USD Million)
- 5.10 Others
- 5.10.1 Others market estimates and forecast, 2021 - 2033 (USD Million)
Chapter 6. AI In Oncology Market Segment Analysis, By Application, 2021 - 2033 (USD Million)
- 6.1 Definition and Scope
- 6.2 Application Market Share Analysis, 2025 & 2033
- 6.3 Segment Dashboard
- 6.4 Global AI In Oncology Market, by Application, 2021 to 2033
- 6.5 Diagnostics (Pathology, Cancer Radiology)
- 6.5.1 Diagnostics (pathology, cancer radiology) market estimates and forecast, 2021 - 2033 (USD Million)
- 6.6 Radiation Therapy (Radiotherapy)
- 6.6.1 Radiation therapy (radiotherapy) market estimates and forecast, 2021 - 2033 (USD Million)
- 6.7 Research & Development (Drug Design, Development Process, etc.)
- 6.7.1 Research & development (drug design, development process, etc.) market estimates and forecast, 2021 - 2033 (USD Million)
- 6.8 Chemotherapy
- 6.8.1 Chemotherapy market estimates and forecast, 2021 - 2033 (USD Million)
- 6.9 Immunotherapy
- 6.8.1 Immunotherapy market estimates and forecast, 2021 - 2033 (USD Million)
Chapter 7. AI In Oncology Market Segment Analysis, By End Use Type, 2021 - 2033 (USD Million)
- 7.1 Definition and Scope
- 7.2 Application Market Share Analysis, 2025 & 2033
- 7.3 Segment Dashboard
- 7.4 Global AI In Oncology Market, by Application, 2021 to 2033
- 7.5 Hospitals
- 7.5.1 Hospitals market estimates and forecast, 2021 - 2033 (USD Million)
- 7.6 Surgical Centers & Medical Institutes
- 7.6.1 Surgical centers & medical institutes market estimates and forecast, 2021 - 2033 (USD Million)
- 7.7 Others (Pharmaceutical Companies, Research Institutes & Training Centers)
- 7.7.1 Others (pharmaceutical companies, research institutes & training centers) market estimates and forecast, 2021 - 2033 (USD Million)
Chapter 8. AI In Oncology Market Segment Analysis, By Region, By Component, By Cancer Type, By Application, By End-use, 2021 - 2033 (USD Million)
- 8.1. Definition & Scope
- 8.2. Regional Market Share Analysis, 2025 & 2033
- 8.3. Regional Market Dashboard
- 8.4. Regional Market Snapshot
- 8.5. SWOT Analysis
- 8.6. North America
- 8.6.1. North America Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.6.2. U.S.
- 8.6.2.1. Key Country Dynamic
- 8.6.2.2. Regulatory Framework
- 8.6.2.3. Competitive Insights
- 8.6.2.4. U.S. Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.6.3. Canada
- 8.6.3.1. Key Country Dynamic
- 8.6.3.2. Regulatory Framework
- 8.6.3.3. Competitive Insights
- 8.6.3.4. Canada Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.7. Europe
- 8.7.1. Europe Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.7.2. Germany
- 8.7.2.1. Key Country Dynamic
- 8.7.2.2. Regulatory Framework
- 8.7.2.3. Competitive Insights
- 8.7.2.4. Germany Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.7.3. UK
- 8.7.3.1. Key Country Dynamic
- 8.7.3.2. Regulatory Framework
- 8.7.3.3. Competitive Insights
- 8.7.3.4. UK Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.7.4. France
- 8.7.4.1. Key Country Dynamic
- 8.7.4.2. Regulatory Framework
- 8.7.4.3. Competitive Insights
- 8.7.4.4. France Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.7.5. Italy
- 8.7.5.1. Key Country Dynamic
- 8.7.5.2. Regulatory Framework
- 8.7.5.3. Competitive Insights
- 8.7.5.4. Italy Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.7.6. Spain
- 8.7.6.1. Key Country Dynamic
- 8.7.6.2. Regulatory Framework
- 8.7.6.3. Competitive Insights
- 8.7.6.4. Spain Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.7.7. Denmark
- 8.7.7.1. Key Country Dynamic
- 8.7.7.2. Regulatory Framework
- 8.7.7.3. Competitive Insights
- 8.7.7.4. Denmark Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.7.8. Sweden
- 8.7.8.1. Key Country Dynamic
- 8.7.8.2. Regulatory Framework
- 8.7.8.3. Competitive Insights
- 8.7.8.4. Sweden Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.7.9. Norway
- 8.7.9.1. Key Country Dynamic
- 8.7.9.2. Regulatory Framework
- 8.7.9.3. Competitive Insights
- 8.7.9.4. Norway Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.8. Asia Pacific
- 8.8.1. Asia Pacific Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.8.2. Japan
- 8.8.2.1. Key Country Dynamic
- 8.8.2.2. Regulatory Framework
- 8.8.2.3. Competitive Insights
- 8.8.2.4. Japan Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.8.3. China
- 8.8.3.1. Key Country Dynamic
- 8.8.3.2. Regulatory Framework
- 8.8.3.3. Competitive Insights
- 8.8.3.4. China Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.8.4. India
- 8.8.4.1. Key Country Dynamic
- 8.8.4.2. Regulatory Framework
- 8.8.4.3. Competitive Insights
- 8.8.4.4. India Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.8.5. South Korea
- 8.8.5.1. Key Country Dynamic
- 8.8.5.2. Regulatory Framework
- 8.8.5.3. Competitive Insights
- 8.8.5.4. South Korea Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.8.6. Australia
- 8.8.6.1. Key Country Dynamic
- 8.8.6.2. Regulatory Framework
- 8.8.6.3. Competitive Insights
- 8.8.6.4. Australia Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.8.7. Thailand
- 8.8.7.1. Key Country Dynamic
- 8.8.7.2. Regulatory Framework
- 8.8.7.3. Competitive Insights
- 8.8.7.4. Thailand Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.9. Latin America
- 8.9.1. Latin America Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.9.2. Brazil
- 8.9.2.1. Key Country Dynamic
- 8.9.2.2. Regulatory Framework
- 8.9.2.3. Competitive Insights
- 8.9.2.4. Brazil Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.9.3. Mexico
- 8.9.3.1. Key Country Dynamic
- 8.9.3.2. Regulatory Framework
- 8.9.3.3. Competitive Insights
- 8.9.3.4. Mexico Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.9.4. Argentina
- 8.9.4.1. Key Country Dynamic
- 8.9.4.2. Regulatory Framework
- 8.9.4.3. Competitive Insights
- 8.9.4.4. Argentina Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.10. MEA
- 8.10.1. MEA Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.10.2. South Africa
- 8.10.2.1. Key Country Dynamic
- 8.10.2.2. Regulatory Framework
- 8.10.2.3. Competitive Insights
- 8.10.2.4. South Africa Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.10.3. Saudi Arabia
- 8.10.3.1. Key Country Dynamic
- 8.10.3.2. Regulatory Framework
- 8.10.3.3. Competitive Insights
- 8.10.3.4. Saudi Arabia Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.10.4. UAE
- 8.10.4.1. Key Country Dynamic
- 8.10.4.2. Regulatory Framework
- 8.10.4.3. Competitive Insights
- 8.10.4.4. UAE Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.10.5. Kuwait
- 8.10.5.1. Key Country Dynamic
- 8.10.5.2. Regulatory Framework
- 8.10.5.3. Competitive Insights
- 8.10.5.4. Kuwait Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
Chapter 9. AI In Oncology Market - Competitive Analysis
- 9.1. Recent Developments & Impact Analysis, by Key Market Participants
- 9.2. Company Categorization
- 9.3. Company Profiles
- 9.3.1. Azra AI
- 9.3.1.1. Overview
- 9.3.1.2. Financial Performance
- 9.3.1.3. Service Benchmarking
- 9.3.1.4. Strategic Initiatives
- 9.3.2. ICAD, INC.
- 9.3.2.1. Overview
- 9.3.2.2. Financial Performance
- 9.3.2.3. Service Benchmarking
- 9.3.2.4. Strategic Initiatives
- 9.3.3. Siemens Healthcare GmbH
- 9.3.3.1. Overview
- 9.3.3.2. Financial Performance
- 9.3.3.3. Service Benchmarking
- 9.3.3.4. Strategic Initiatives
- 9.3.4. Intel Corporation
- 9.3.4.1. Overview
- 9.3.4.2. Financial Performance
- 9.3.4.3. Service Benchmarking
- 9.3.4.4. Strategic Initiatives
- 9.3.5. GE HealthCare
- 9.3.5.1. Overview
- 9.3.5.2. Financial Performance
- 9.3.5.3. Service Benchmarking
- 9.3.5.4. Strategic Initiatives
- 9.3.6. NVIDIA Corporation
- 9.3.6.1. Overview
- 9.3.6.2. Financial Performance
- 9.3.6.3. Service Benchmarking
- 9.3.6.4. Strategic Initiatives
- 9.3.7. Digital Diagnostics Inc.
- 9.3.7.1. Overview
- 9.3.7.2. Financial Performance
- 9.3.7.3. Service Benchmarking
- 9.3.7.4. Strategic Initiatives
- 9.3.8. ConcertAI
- 9.3.8.1. Overview
- 9.3.8.2. Financial Performance
- 9.3.8.3. Service Benchmarking
- 9.3.8.4. Strategic Initiatives
- 9.3.9. Median Technologies
- 9.3.9.1. Overview
- 9.3.9.2. Financial Performance
- 9.3.9.3. Service Benchmarking
- 9.3.9.4. Strategic Initiatives
- 9.3.10. PathAI
- 9.3.10.1. Overview
- 9.3.10.2. Financial Performance
- 9.3.10.3. Service Benchmarking
- 9.3.10.4. Strategic Initiatives
- 9.3.11. MVision AI
- 9.3.11.1. Overview
- 9.3.11.2. Financial Performance
- 9.3.11.3. Service Benchmarking
- 9.3.11.4. Strategic Initiatives
- 9.3.1. Azra AI
Product Code: GVR-4-68039-985-7
List of Tables
- Table 1 List of Secondary Sources
- Table 2 List of Abbreviations
- Table 3 Global ai in oncology market, by region, 2021 - 2033 (USD Million)
- Table 4 Global ai in oncology market, by component, 2021 - 2033 (USD Million)
- Table 5 Global ai in oncology market, by cancer type, 2021 - 2033 (USD Million)
- Table 6 Global ai in oncology market, by application, 2021 - 2033 (USD Million)
- Table 7 Global ai in oncology market, by end use, 2021 - 2033 (USD Million)
- Table 8 North America AI in oncology market, by region, 2021 - 2033 (USD Million)
- Table 9 North America AI in oncology market, by component, 2021 - 2033 (USD Million)
- Table 10 North America AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
- Table 11 North America AI in oncology market, by application, 2021 - 2033 (USD Million)
- Table 12 North America AI in oncology market, by end-use, 2021 - 2033 (USD Million)
- Table 13 U.S. AI in oncology market, by component, 2021 - 2033 (USD Million)
- Table 14 U.S. AI in oncology market, by application, 2021 - 2033 (USD Million)
- Table 15 U.S. AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
- Table 16 U.S. AI in oncology market, by end-use, 2021 - 2033 (USD Million)
- Table 17 Canada AI in oncology market, by component, 2021 - 2033 (USD Million)
- Table 18 Canada AI in oncology market, by application, 2021 - 2033 (USD Million)
- Table 19 Canada AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
- Table 20 Canada AI in oncology market, by end-use, 2021 - 2033 (USD Million)
- Table 21 Europe AI in oncology market, by region, 2021 - 2033 (USD Million)
- Table 22 Europe AI in oncology market, by component, 2021 - 2033 (USD Million)
- Table 23 Europe AI in oncology market, by application, 2021 - 2033 (USD Million)
- Table 24 Europe AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
- Table 25 Europe AI in oncology market, by end-use, 2021 - 2033 (USD Million)
- Table 26 Germany AI in oncology market, by component, 2021 - 2033 (USD Million)
- Table 27 Germany AI in oncology market, by application, 2021 - 2033 (USD Million)
- Table 28 Germany AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
- Table 29 Germany AI in oncology market, by end-use, 2021 - 2033 (USD Million)
- Table 30 UK AI in oncology market, by component, 2021 - 2033 (USD Million)
- Table 31 UK AI in oncology market, by application, 2021 - 2033 (USD Million)
- Table 32 UK AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
- Table 33 UK AI in oncology market, by end-use, 2021 - 2033 (USD Million)
- Table 34 France AI in oncology market, by component, 2021 - 2033 (USD Million)
- Table 35 France AI in oncology market, by application, 2021 - 2033 (USD Million)
- Table 36 France AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
- Table 37 France AI in oncology market, by end-use, 2021 - 2033 (USD Million)
- Table 38 Italy AI in oncology market, by component, 2021 - 2033 (USD Million)
- Table 39 Italy AI in oncology market, by application, 2021 - 2033 (USD Million)
- Table 40 Italy AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
- Table 41 Italy AI in oncology market, by end-use, 2021 - 2033 (USD Million)
- Table 42 Spain AI in oncology market, by component, 2021 - 2033 (USD Million)
- Table 43 Spain AI in oncology market, by application, 2021 - 2033 (USD Million)
- Table 44 Spain AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
- Table 45 Spain AI in oncology market, by end-use, 2021 - 2033 (USD Million)
- Table 46 Denmark AI in oncology market, by component, 2021 - 2033 (USD Million)
- Table 47 Denmark AI in oncology market, by application, 2021 - 2033 (USD Million)
- Table 48 Denmark AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
- Table 49 Denmark AI in oncology market, by end-use, 2021 - 2033 (USD Million)
- Table 50 Sweden AI in oncology market, by component, 2021 - 2033 (USD Million)
- Table 51 Sweden AI in oncology market, by application, 2021 - 2033 (USD Million)
- Table 52 Sweden AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
- Table 53 Sweden AI in oncology market, by end-use, 2021 - 2033 (USD Million)
- Table 54 Norway AI in oncology market, by component, 2021 - 2033 (USD Million)
- Table 55 Norway AI in oncology market, by application, 2021 - 2033 (USD Million)
- Table 56 Norway AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
- Table 57 Norway AI in oncology market, by end-use, 2021 - 2033 (USD Million)
- Table 58 Asia Pacific AI in oncology market, by region, 2021 - 2033 (USD Million)
- Table 59 Asia Pacific AI in oncology market, by component, 2021 - 2033 (USD Million)
- Table 60 Asia Pacific AI in oncology market, by application, 2021 - 2033 (USD Million)
- Table 61 Asia Pacific AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
- Table 62 Asia Pacific AI in oncology market, by end-use, 2021 - 2033 (USD Million)
- Table 63 China AI in oncology market, by component, 2021 - 2033 (USD Million)
- Table 64 China AI in oncology market, by application, 2021 - 2033 (USD Million)
- Table 65 China AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
- Table 66 China AI in oncology market, by end-use, 2021 - 2033 (USD Million)
- Table 67 Japan AI in oncology market, by component, 2021 - 2033 (USD Million)
- Table 68 Japan AI in oncology market, by application, 2021 - 2033 (USD Million)
- Table 69 Japan AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
- Table 70 Japan AI in oncology market, by end-use, 2021 - 2033 (USD Million)
- Table 71 India AI in oncology market, by component, 2021 - 2033 (USD Million)
- Table 72 India AI in oncology market, by application, 2021 - 2033 (USD Million)
- Table 73 India AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
- Table 74 India AI in oncology market, by end-use, 2021 - 2033 (USD Million)
- Table 75 South Korea AI in oncology market, by component, 2021 - 2033 (USD Million)
- Table 76 South Korea AI in oncology market, by application, 2021 - 2033 (USD Million)
- Table 77 South Korea AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
- Table 78 South Korea AI in oncology market, by end-use, 2021 - 2033 (USD Million)
- Table 79 Australia AI in oncology market, by component, 2021 - 2033 (USD Million)
- Table 80 Australia AI in oncology market, by application, 2021 - 2033 (USD Million)
- Table 81 Australia AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
- Table 82 Australia AI in oncology market, by end-use, 2021 - 2033 (USD Million)
- Table 83 Thailand AI in oncology market, by component, 2021 - 2033 (USD Million)
- Table 84 Thailand AI in oncology market, by application, 2021 - 2033 (USD Million)
- Table 85 Thailand AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
- Table 86 Thailand AI in oncology market, by end-use, 2021 - 2033 (USD Million)
- Table 87 Latin America AI in oncology market, by region, 2021 - 2033 (USD Million)
- Table 88 Latin America AI in oncology market, by component, 2021 - 2033 (USD Million)
- Table 89 Latin America AI in oncology market, by application, 2021 - 2033 (USD Million)
- Table 90 Latin America AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
- Table 91 Latin America AI in oncology market, by end-use, 2021 - 2033 (USD Million)
- Table 92 Brazil AI in oncology market, by component, 2021 - 2033 (USD Million)
- Table 93 Brazil AI in oncology market, by application, 2021 - 2033 (USD Million)
- Table 94 Brazil AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
- Table 95 Brazil AI in oncology market, by end-use, 2021 - 2033 (USD Million)
- Table 96 Mexico AI in oncology market, by component, 2021 - 2033 (USD Million)
- Table 97 Mexico AI in oncology market, by application, 2021 - 2033 (USD Million)
- Table 98 Mexico AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
- Table 99 Mexico AI in oncology market, by end-use, 2021 - 2033 (USD Million)
- Table 100 Argentina AI in oncology market, by component, 2021 - 2033 (USD Million)
- Table 101 Argentina AI in oncology market, by application, 2021 - 2033 (USD Million)
- Table 102 Argentina AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
- Table 103 Argentina AI in oncology market, by end-use, 2021 - 2033 (USD Million)
- Table 104 MEA AI in oncology market, by region, 2021 - 2033 (USD Million)
- Table 105 MEA AI in oncology market, by component, 2021 - 2033 (USD Million)
- Table 106 MEA AI in oncology market, by application, 2021 - 2033 (USD Million)
- Table 107 MEA AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
- Table 108 MEA AI in oncology market, by end-use, 2021 - 2033 (USD Million)
- Table 109 South Africa AI in oncology market, by component, 2021 - 2033 (USD Million)
- Table 110 South Africa AI in oncology market, by application, 2021 - 2033 (USD Million)
- Table 111 South Africa AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
- Table 112 South Africa AI in oncology market, by end-use, 2021 - 2033 (USD Million)
- Table 113 Saudi Arabia AI in oncology market, by component, 2021 - 2033 (USD Million)
- Table 114 Saudi Arabia AI in oncology market, by application, 2021 - 2033 (USD Million)
- Table 115 Saudi Arabia AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
- Table 116 Saudi Arabia AI in oncology market, by end-use, 2021 - 2033 (USD Million)
- Table 117 UAE AI in oncology market, by component, 2021 - 2033 (USD Million)
- Table 118 UAE AI in oncology market, by application, 2021 - 2033 (USD Million)
- Table 119 UAE AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
- Table 120 UAE AI in oncology market, by end-use, 2021 - 2033 (USD Million)
- Table 121 Kuwait AI in oncology market, by component, 2021 - 2033 (USD Million)
- Table 122 Kuwait AI in oncology market, by application, 2021 - 2033 (USD Million)
- Table 123 Kuwait AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
- Table 124 Kuwait AI in oncology market, by end-use, 2021 - 2033 (USD Million)
List of Figures
- Fig. 1 AI in oncology market segmentation
- Fig. 2 Market research process
- Fig. 3 Information procurement
- Fig. 4 Commodity flow analysis
- Fig. 5 Parent market analysis
- Fig. 6 AI in oncology Market snapshot
- Fig. 7 AI in oncology Market segment snapshot
- Fig. 8 AI in oncology Market segment snapshot
- Fig. 9 AI in oncology Market competitive landscape snapshot
- Fig. 10 Market research process
- Fig. 11 Parent market outlook (USD Billion) (2025)
- Fig. 12 AI in oncology market dynamics
- Fig. 13 Areas of interest most likely to benefit from AI in the next 10 years
- Fig. 14 Anticipated Clinical Impact: Key Areas where AI is Poised to Make a Significant Difference
- Fig. 15 Comparison between AI-integrated healthcare and traditional healthcare
- Fig. 16 Porter's Analysis
- Fig. 17 PESTEL Analysis
- Fig. 18 AI in oncology market, component outlook key takeaways (USD Million)
- Fig. 19 AI in oncology market: Component movement analysis, 2025 & 2033 (USD Million)
- Fig. 20 Software solutions market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 21 Hardware market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 22 Services market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 23 AI in cancer diagnostics market, cancer type outlook key takeaways (USD Million)
- Fig. 24 AI in oncology market: Cancer type movement analysis, 2025 & 2033 (USD Million)
- Fig. 25 Breast cancer market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 26 Lung cancer market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 27 Prostate cancer market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 28 Colorectal cancer market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 29 Brain tumor market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 30 Others market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 31 AI in cancer diagnostics market, application outlook key takeaways (USD Million)
- Fig. 32 AI in oncology market: Application movement analysis, 2025 & 2033 (USD Million)
- Fig. 33 Diagnostics (pathology, cancer radiology) market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 34 Radiation therapy (Radiotherapy) market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 35 Chemotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 36 Immunotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 37 Research & development market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 38 AI in oncology market, end-use outlook key takeaways (USD Million)
- Fig. 39 AI in oncology market: End-user movement analysis, 2025 & 2033 (USD Million)
- Fig. 40 Hospitals market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 41 Surgical centers and medical institutes market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 42 Others market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 43 Regional marketplace: Key takeaways
- Fig. 44 AI in Oncology market: Regional outlook, 2025 & 2033 (USD Million)
- Fig. 45 AI in Oncology market: Regional outlook, 2025 & 2033 (USD Million)
- Fig. 46 North America AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 47 Key country dynamics
- Fig. 48 U.S. AI in oncology market estimates and forecasts, 2021 - 2033 (USD billion)
- Fig. 49 U.S. AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 50 Key country dynamics
- Fig. 51 Canada AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 52 Europe AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 53 Key country dynamics
- Fig. 54 UK AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 55 Key country dynamics
- Fig. 56 Germany AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 57 Key country dynamics
- Fig. 58 Spain AI In oncology market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 59 Key country dynamics
- Fig. 60 France AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 61 Key country dynamics
- Fig. 62 Italy AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million )
- Fig. 63 Key country dynamics
- Fig. 64 Norway AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 65 Key country dynamics
- Fig. 66 Denmark AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 67 Key country dynamics
- Fig. 68 Sweden AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 69 Asia Pacific AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million )
- Fig. 70 Key country dynamics
- Fig. 71 Japan AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 72 Key country dynamics
- Fig. 73 China AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 74 Key country dynamics
- Fig. 75 India AI In oncology market estimates and forecasts, 2021 - 2033 (USD Million )
- Fig. 76 Key country dynamics
- Fig. 77 Australia AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million )
- Fig. 78 Key country dynamics
- Fig. 79 South Korea AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million )
- Fig. 80 Key country dynamics
- Fig. 81 Thailand AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 82 Latin America AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million )
- Fig. 83 Key country dynamics
- Fig. 84 Brazil AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 85 Key country dynamics
- Fig. 86 Mexico AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million )
- Fig. 87 Key country dynamics
- Fig. 88 Argentina AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million )
- Fig. 89 MEA AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 90 Key country dynamics
- Fig. 91 South Africa AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 92 Key country dynamics
- Fig. 93 Saudi Arabia AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 94 Key country dynamics
- Fig. 95 UAE AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 96 Key country dynamics
- Fig. 97 Kuwait AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 98 Key company categorization
- Fig. 99 Heat map analysis
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.